论文部分内容阅读
乙型肝炎１００例经抗乙肝胎盘转移因子治疗获得临床治愈后，肝活检复查证明急性乙肝平均３个月后肝组织病理基本正常者仅１５．４％，明显进步６１．５％，提示出院后仍需巩固治疗。慢活肝和慢活肝伴早期肝硬变者经本剂治后，肝活检复查示病理形态明显进步者，观察组显著多于对照组，早期肝硬变的病理改变治后可获消退，代偿期肝硬变的病理形态改变亦可获进步。因此，初步证明肝硬变的病理形态是可逆转的，抗乙肝胎盘转移因子可以提高逆转率。
Hepatitis B 100 patients after anti-hepatitis B placental transfer factor therapy clinically cured, the liver biopsy review showed that the average of 3 months after the acute hepatitis B liver pathology was normal only 15.4%, significantly improved 61.5%, suggesting that after discharge Still need to consolidate treatment. Slow living liver and slow living liver with early liver cirrhosis by the treatment of the liver, liver biopsy showed pathological manifestations were significantly improved, the observation group was significantly more than the control group, the pathological changes of early cirrhosis can be subsided after treatment, Compensatory cirrhosis of the pathological changes can also be improved. Therefore, preliminary evidence of liver cirrhosis is reversible pathology, anti-hepatitis B placental transfer factor can improve the reversal rate.